The Affordable Care Act: Effects of Insurance on Diabetes Biomarkers.
Miguel MarinoHeather AngierRachel SpringerSteele ValenzuelaMegan HoopesJean O'MalleyAndrew SuchockiJohn HeintzmanJennifer DeVoeNathalie HuguetPublished in: Diabetes care (2020)
Post-ACA, newly insured patients had greater improvements in diabetes-related biomarkers than continuously uninsured, discontinuously insured, or continuously insured patients. Findings suggest that health insurance gain via ACA facilitates access to appropriate diabetes care, leading to improvements in diabetes-related biomarkers.